Company news
Medcap Ab (OMXSTO:MCAP) news
Medcap Ab news releases on 6ix. Latest, Jun 26, 2026: MedCap Signs Agreement To Acquire Biopsafe In Denmark
Press releases & updates
MedCap Signs Agreement To Acquire Biopsafe In Denmark
June 26, 2026
MedCap Completes Buyback Program
May 20, 2026
MCAP: Q1 2026 delivered double-digit revenue and profit growth, driven by strong segment performance
April 29, 2026
MedCap (Q4 review): Beat on Solid Organic Growth
February 11, 2026
MCAP: Record sales and EBITA growth in 2025, supported by strong operations and acquisitions
February 6, 2026
MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas
January 8, 2026
MCAP: Q3 2025 delivered 21% sales growth, 32% EBITA growth, and strong segment performance
October 24, 2025
Abilia Acquires Livassured
October 1, 2025
MCAP: Q2 2025 delivered double-digit sales and EBITA growth, with strong M&A momentum
July 23, 2025
MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma
July 21, 2025
MedCap's Business Area Specialty Pharma Acquires XGX Pharma
June 25, 2025
MCAP: Q1 2025 delivered 7% sales growth, 17% EBITA margin, and strong M&A prospects
April 29, 2025
MCAP: Achieved SEK 1,807 million revenue in 2024 with a 23% EBITA CAGR, driven by acquisitions
March 10, 2025
MCAP: Q4 sales up 4%, but EBITA down 27% as Specialty Pharma faces royalty and pricing headwinds
January 31, 2025
MCAP: Strong growth in life science through buy & build, with 19% sales and 29% EBITA CAGR
November 14, 2024
MCAP: Q3 2024 delivered double-digit sales growth, led by Assistive Tech and MedTech strength
October 25, 2024
MCAP: Q2 sales up 19% and EBITA up 13%, with robust growth in Assistive Tech and MedTech
July 24, 2024